Patients will demand transparency and value, expecting personalized, data-rich experiences with clear prices and quality ...
The oral versions may set records in 2026, and glucagon-like peptide 1 (GLP-1) drugs will pick up even more momentum as ...
By 2027, most private insurance plans must cover HPV screening and follow-up testing without cost-sharing, reducing financial ...
According to telehealth.org, policy changes have also helped telehealth become a permanent option for Medicare patients. The Consolidated Appropriations Acts of 2021 and 2023 removed limits on where ...
The CDC has reduced the number of recommended childhood vaccines from 17 down to 11, according to a decision memorandum ...
GLP-1 drugs are 36% more effective than aspirin in reducing colorectal cancer risk, with fewer side effects like acute kidney ...
Long-term Medicaid expansion was linked to substantial growth in PrEP prescribing, with earlier expansion states seeing far ...
Primary care must ensure that patients have access to the full spectrum of preventive tools, including nutrition services, to ...
At the 2025 AMCP annual meeting in Houston, John M. O'Brien, Pharm.D., M.P.H., president and CEO of the National ...
Primary care must ensure that patients have access to the full spectrum of preventive tools, including nutrition services, to ...
Since 2019, three disease-specific therapies have been approved to treat patients with ATTR-CM. The first was Pfizer’s Vyndamax (tafamidis) in May 2019, which was approved for both wild type and ...
Gastric cancer cells can activate KRAS-driven signals, enabling autonomous tumor growth by producing their own WNT proteins. New research reveals how gastric cancer cells exploit WNT signaling for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback